Carroll Investors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Carroll Investors's BMY Position: Q2 2022 in Review
Carroll Investors sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 1,160 shares — an estimated $84K sold.
Carroll Investors first reported a position in BMY in Q4 2021 and held it in 2 quarters. The position peaked at $84K in Q1 2022. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.
- Carroll Investors reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
- Carroll Investors sold 1,160 Bristol-Myers Squibb shares in Q2 2022, an estimated $84K.
- Carroll Investors first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 2 quarters.
- Carroll Investors's Bristol-Myers Squibb position peaked at $84K in Q1 2022.
- 2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.
Based on Carroll Investors's 13F filing for Q2 2022, filed 26 Jul 2022.